BMT Doctors
Yue Lu

Hematologist

Clinical Professor

Clinical focus

Leukemia, Multiple myeloma, Lymphoma, Aplastic anemia, Thrombocytopenia.

Autoimmune blood disease.

Benign and malignant blood diseases and hereditary diseases.

HSCT, HSCT complications (GVHD, infection etc.)

Board Certification

Chinese Board of Internal Medicine

Education

Visiting Fellow, Fred Hutchinson Cancer Research Center (2016)

M.D., Xiangya School of Medicine, Central South University (2004)

Work Experience

Clinical Professor, HSCT Department, Lu Daopei Hospital (2004-present)

Achievements

Completed over 400 HSCT cases

Publications

Published articles on HSCT on professional journals in China

Presented speeches in domestic and international medical conferences.

1、Effect of NCCN (2015) risk stratification on prognosis of patients with acute myeioid leukemia after allogeneic hematopoietic stem cell transplantation

Lu Yue, Wu Tong, Zhao Yanli, Cao Xingyu, Liu Deyan, Zhang Jianping, Xiong Min, Zhou Jiarui, Sun Ruijuan, Wei Zhijie, Wang Hui, Liu Hongxing, Wang Tong, Tong Chunrong, Ji Shuquan, Lu Daopei.(2017).Effect of NCCN (2015) risk stratification on prognosis of patients with acute myeioid leukemia after allogeneic hematopoietic stem cell transplantation.Chinese Journal of Hematology,38(01):4449.

2、Effect of minimal residual disease monitoring by multiparameter flow cytometry preconditioning on prognosis of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation

 Lu Yue, Wu Tong, Wang Hui, Zhao Yanli, Cao Xingyu, Liu Deyan, Zhang Jianping, Xiong Min, Zhou Jiarui, Sun Ruijuan, Wei Zhijie, Ji Shuquan, Lu Daopei,(2017).Effect of minimal residual disease monitoring by multiparameter flow cytometry preconditioning on prognosis of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation.Chinese Journal of Hematology,38(02):118123.

3、Comparison of three different types of donor hematopoietic stem cell transplantation forintermediate and highrisk myelodysplastic syndrome

Lu Yue, Wu Tong, Zhao Yanli, Cao Xingyu, Liu Deyan, Xiong Min, Zhou Jiarui, Zhang Jianping, Wei Zho'ie, Sun Ruij'uan, Lu Daopei.(2017).Comparison of three different types of donor hematopoietic stem cell transplantation forintermediate and highrisk myelodysplastic syndrome.  Chinese Journal of Hematology,38(042):301306.

4、12 cases analysis of Allogeneic hematopoietic stem cell transplantation with myeloablative dose preconditioning in more than 55years old of  highrisk malignant  Hematologic patients

Lu Yue,et al.(2016).12 cases analysis of Allogeneic hematopoietic stem cell transplantation with myeloablative dose preconditioning in more than 55years old of  highrisk malignant  Hematologic patients. Chinese Journal of Hematology,37(08):708711

5、HLAhaploidentical donor hematopoietic transplantation for severe aplastic anemia achieved comparable outcomes with HLAunrelated donor transplantation

Lu Yue, Wu Tong, Cao Xingyu, Zhao Yanli, Liu Deyan, Sun Ruijuan, Xiong Min, Wei Zho'ie, Zhang Jianping, Zhou Jiarui, Lu Daopei.(2016).HLAhaploidentical donor hematopoietic transplantation for severe aplastic anemia achieved comparable outcomes with HLAunrelated donor transplantation. Chinese Journal of Hematology,37(01):3538

6、Effects of allogeneic hematopoietic stem cell transplantation on 60 patients with myelodysplastic syndrome

LU Yue, WU Tong, CAO Xingyu, WANG Jingbo, YIN Yuming, LU Daopei.(2010).Effects of allogeneic hematopoietic stem cell transplantation on 60 patients with myelodysplastic syndrome.Chinese Journal of Internal Medicine,49(3):200203.

7、Significant reduction of morbidity and mortality of early CMV disease after allogeneic hematopoietic cell transplantation by preemptive therapy with antiviral drugs and CMV cytotoxic T lymphocytes

LU Yue WU Tong CAO Xingyu WANG Jingbo SUN Yuan ZHAO Yanli DA Wanming JI Shuquan TONG Chunrong ZHANG Longji LU Daopei.(2011).Significant reduction of morbidity and mortality of early CMV disease after allogeneic hematopoietic cell transplantation by preemptive therapy with antiviral drugs and CMV cytotoxic T lymphocytes.Journal of Clinical Hematology, 24(11):655661.

8、Tuberculous infections following allogeneic hematopoietic stem cell transplantation

LU Yue,WU Tong,CAO Xingyu ,WEI Linyi, ZHOU Jiarui ,LU Daopei.(2011).Tuberculous infections following allogeneic hematopoietic stem cell transplantation. Journal of Clinical Hematology,24(7): 391393.

9、Monitoring of early EpsteinBarr virus reactivation and preemptive therapy after allogeneic hematopoietic stem cell transplantation

LU Yue, WU Tong, CAO Xingyu, WANG Jingbo, SUN Yuan, ZHAO Yanli, DA Wanming, JI Shuquan, TONG Chunrong, LU Daopei.(2011).Monitoring of early EpsteinBarr virus reactivation and preemptive therapy after allogeneic hematopoietic stem cell transplantation.Chinese Journal of Internal Medicine, 50(5):383387.

10、 one case report of Non consanguineous peripheral blood hematopoietic stem cell transplantation for T cell large granular lymphoblastic leukemia and pure red cell aplastic anemia

Lu Yue,et al.(2010). one case report of Non consanguineous peripheral blood hematopoietic stem cell transplantation for T cell large granular lymphoblastic leukemia and pure red cell aplastic anemia. National Medical Journal of China,90(4):287288.

participated in editing books:

participated in editing the new version of academician Lu Daopei“Leukemia therapeutics”, editing the chapter of “Allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome”


Stay in Touch
©2017 Lu Daopei hospital-22 Tongji South Rd, Yizhuang Ecomonic and Technological Development Zone, Daxing District, Beijing, China. All rights reserved.
   京公网安备13108202000843号      冀ICP备18002416号-1